AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35618380 — intervention group
Group type: COMPARATOR
Intervention: Individual coaching
Number of subjects: 252
Study 35618380 — intervention group
Group type: COMPARATOR
Intervention: Non-coached conditions
Number of subjects: 252
Study 34362266 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver Skills Training (n = 43)
Number of subjects: 86
Study 34362266 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (n = 43)
Number of subjects: 86
Study 36399201 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater cold snare polypectomy
Number of subjects: 398
Study 36399201 — intervention group
Group type: COMPARATOR
Intervention: Conventional cold snare polypectomy
Number of subjects: 398
Study 36337273 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycopene (25 mg once a day for 8 weeks)
Number of subjects: 50
Study 36337273 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch tablets once a day for 8 weeks)
Number of subjects: 50
Study 34020976 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial counselling
Number of subjects: 180
Study 34020976 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus information from a government money advice website
Number of subjects: 180
Study 35075752 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablative fractional CO2 laser combined with autologous platelet-rich plasma (PRP)
Number of subjects: 16
Study 35075752 — intervention group
Group type: COMPARATOR
Intervention: Ablative fractional CO2 laser and placebo (plain normal saline solution)
Number of subjects: 16
Study 33032897 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 71
Study 33032897 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 71
Study 34183640 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS (1 week of iTBS/2 weeks of sham, 2 weeks of iTBS/1 week of sham, or 3 weeks of iTBS)
Number of subjects: 36
Study 34183640 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS (G₁₋₃ combined)
Number of subjects: 36
Study 34183640 — intervention group
Group type: COMPARATOR
Intervention: Sham (G₀)
Number of subjects: 36
Study 33248596 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-based purified diet
Number of subjects: 48
Study 33248596 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental diets with 957 g/kg inclusion of grains (corn, sorghum, wheat, barley)
Number of subjects: 48
Study 35777931 — intervention group
Group type: EXPERIMENTAL
Intervention: Extrafascial injection
Number of subjects: 50
Study 35777931 — intervention group
Group type: COMPARATOR
Intervention: Intrafascial injection
Number of subjects: 50
Study 33539971 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab added to adjuvant chemotherapy
Number of subjects: 1501
Study 33539971 — intervention group
Group type: COMPARATOR
Intervention: Never smokers
Number of subjects: 1501
Study 33539971 — intervention group
Group type: COMPARATOR
Intervention: Former smokers
Number of subjects: 1501
Study 33539971 — intervention group
Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 1501
Study 33539971 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers at enrollment
Number of subjects: 1501
Study 33539971 — intervention group
Group type: EXPERIMENTAL
Intervention: Respondents at 12 months
Number of subjects: 1501
Study 32951746 — intervention group
Group type: EXPERIMENTAL
Intervention: Oak Gall vaginal cream
Number of subjects: 84
Study 32951746 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole vaginal gel
Number of subjects: 84
Study 33477151 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery Rescripting
Number of subjects: 96
Study 33477151 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal Exposure
Number of subjects: 96
Study 33477151 — intervention group
Group type: COMPARATOR
Intervention: Positive Imagery
Number of subjects: 96
Study 32227140 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term exposure to PM2.5 (0.88 μg/m3 increase)
Number of subjects: 2927
Study 32227140 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term exposure to NOx (8.35 μg/m3 increase)
Number of subjects: 2927
Study 32227140 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure (PM2.5 exposure)
Number of subjects: 2927
Study 32227140 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure (NOx exposure)
Number of subjects: 2927
Study 32227140 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic heart disease (PM2.5 exposure)
Number of subjects: 2927
Study 32227140 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic heart disease (NOx exposure)
Number of subjects: 2927
Study 32227140 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke as an intermediate condition
Number of subjects: 2927
Study 35350937 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan (50 mg, 100 mg, or 200 mg)
Number of subjects: 7920
Study 35350937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7920
Study 33377146 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a sweepstakes offer
Number of subjects: 5244
Study 33377146 — intervention group
Group type: EXPERIMENTAL
Intervention: Outdoors settings, flora imagery, natural descriptors, and environmental themes
Number of subjects: 5244
Study 33377146 — intervention group
Group type: EXPERIMENTAL
Intervention: Price reductions (e.g., coupons)
Number of subjects: 5244
Study 35129520 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis
Number of subjects: 89
Study 35129520 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal anastomosis
Number of subjects: 89
Study 33969592 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg, daily)
Number of subjects: 19
Study 33969592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 33969592 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 19
Study 36123374 — intervention group
Group type: EXPERIMENTAL
Intervention: Bambara groundnut genotypes
Number of subjects: 30
Study 34354179 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg QD
Number of subjects: 20
Study 34354179 — intervention group
Group type: COMPARATOR
Intervention: simvastatin 40 mg combined with ezetimibe 10 mg QD
Number of subjects: 20
Study 32696603 — intervention group
Group type: EXPERIMENTAL
Intervention: Savoring an exciting memory
Number of subjects: 1238
Study 32696603 — intervention group
Group type: EXPERIMENTAL
Intervention: Savoring a calm memory
Number of subjects: 1238
Study 32696603 — intervention group
Group type: COMPARATOR
Intervention: Control condition (what they did today and yesterday)
Number of subjects: 1238
Study 32346779 — intervention group
Group type: EXPERIMENTAL
Intervention: Two suture-button systems (group A)
Number of subjects: 36
Study 32346779 — intervention group
Group type: EXPERIMENTAL
Intervention: One suture-button system and an autologous gracilis tendon graft (group B)
Number of subjects: 36
Study 32109848 — intervention group
Group type: EXPERIMENTAL
Intervention: High intratumoral DC-SIGN+ macrophages infiltration
Number of subjects: 504
Study 32109848 — intervention group
Group type: EXPERIMENTAL
Intervention: High infiltration of DC-SIGN+ macrophages
Number of subjects: 504
Study 32109848 — intervention group
Group type: EXPERIMENTAL
Intervention: CD8+ T cells in DC-SIGN+ macrophages high subgroup
Number of subjects: 504
Study 35442613 — intervention group
Group type: EXPERIMENTAL
Intervention: PIBI+CI
Number of subjects: 74
Study 35442613 — intervention group
Group type: COMPARATOR
Intervention: CI
Number of subjects: 74
Study 35442613 — intervention group
Group type: COMPARATOR
Intervention: PIBI
Number of subjects: 74
Study 33713522 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy (LLLT) using Hair Growth System (TOPHAT655) for 20 minutes, two sessions per week for 16 weeks (total of 32 treatments).
Number of subjects: 20
Study 34357723 — intervention group
Group type: EXPERIMENTAL
Intervention: Transillumination method
Number of subjects: 450
Study 34357723 — intervention group
Group type: COMPARATOR
Intervention: Visual inspection
Number of subjects: 450
Study 32407638 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial rheoplasty
Number of subjects: 30
Study 36163181 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician champion intervention
Number of subjects: 2
Study 36163181 — intervention group
Group type: COMPARATOR
Intervention: Control clinics
Number of subjects: 2
Study 36163181 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative thematic analysis of clinician champions' documentation
Number of subjects: 2
Study 33770169 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition to higher risk of T2D
Number of subjects: 133010
Study 33770169 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of fasting insulin
Number of subjects: 133010
Study 33770169 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting insulin
Number of subjects: 133010
Study 32932881 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant Milking Technology applied to Morus alba L. (mulberry tree)
Number of subjects: 0
Study 35444013 — intervention group
Group type: EXPERIMENTAL
Intervention: Dostarlimab as maintenance therapy after chemoradiation
Number of subjects: 132
Study 35444013 — intervention group
Group type: COMPARATOR
Intervention: Clinical and radiological follow-up (control)
Number of subjects: 132
Study 34836020 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB-enriched oral nutritional supplements (ONS) - 220 mL of Ensure® Plus Advance, twice a day for 12 weeks
Number of subjects: 43
Study 34836020 — intervention group
Group type: COMPARATOR
Intervention: HP oral nutritional supplements (ONS) - 220 mL of Ensure® Plus High Protein, twice a day for 12 weeks
Number of subjects: 43
Study 34836020 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (HMB and HP)
Number of subjects: 43
Study 34836020 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB-enriched ONS
Number of subjects: 43
Study 34836020 — intervention group
Group type: EXPERIMENTAL
Intervention: MHE evaluation
Number of subjects: 43
Study 32106777 — intervention group
Group type: EXPERIMENTAL
Intervention: Revefenacin 175 µg
Number of subjects: 0
Study 32106777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32106777 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium 18 µg
Number of subjects: 0
Study 35325513 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of percentage of energy intake from ultra-processed foods (PEI-UPF)
Number of subjects: 156
Study 34526061 — intervention group
Group type: EXPERIMENTAL
Intervention: Support mechanisms for research generation and utilization (self‐administered cross‐sectional survey using m‐SATORI)
Number of subjects: 258
Study 35776203 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP with applicator brush
Number of subjects: 40
Study 35776203 — intervention group
Group type: COMPARATOR
Intervention: 35% HP without applicator brush
Number of subjects: 40
Study 35776203 — intervention group
Group type: EXPERIMENTAL
Intervention: 37.5% HP with applicator brush
Number of subjects: 40
Study 35776203 — intervention group
Group type: COMPARATOR
Intervention: 37.5% HP without applicator brush
Number of subjects: 40
Study 33554391 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic counseling with prior education via a Web platform
Number of subjects: 120
Study 33554391 — intervention group
Group type: COMPARATOR
Intervention: Genetic counseling without additional education
Number of subjects: 120
Study 34933146 — intervention group
Group type: EXPERIMENTAL
Intervention: Double layered purse string uterine suture (PSUS)
Number of subjects: 100
Study 34933146 — intervention group
Group type: COMPARATOR
Intervention: Single layer continuous uterine suture (SLCUS)
Number of subjects: 100
Study 35638576 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation therapy using mobile applications
Number of subjects: 0
Study 35638576 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34117184 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined upper limb exercise training (ULET)
Number of subjects: 36
Study 34117184 — intervention group
Group type: COMPARATOR
Intervention: Strength upper limb exercise training (ULET)
Number of subjects: 36
Study 32846388 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion meditations
Number of subjects: 70
Study 32846388 — intervention group
Group type: COMPARATOR
Intervention: Nature-focused guided imagery meditations
Number of subjects: 70
Study 32643473 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet rich plasma (PRP) injection
Number of subjects: 40
Study 32643473 — intervention group
Group type: COMPARATOR
Intervention: Topical erythromycin 2%
Number of subjects: 40
Study 35770300 — intervention group
Group type: EXPERIMENTAL
Intervention: ART FILLER® Volume
Number of subjects: 0
Study 35770300 — intervention group
Group type: COMPARATOR
Intervention: Juvéderm Voluma®
Number of subjects: 0
Study 33402258 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 70
Study 33402258 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 70
Study 32235569 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble Corn Fiber (SCF)
Number of subjects: 22
Study 32235569 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin
Number of subjects: 22
Study 85198193 — intervention group
Group type: COMPARATOR
Intervention: Placebo group in a hepatitis B vaccine trial
Number of subjects: 236
Study 36284024 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 18
Study 36284024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 18
Study 36284024 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot Water Immersion (HWI)
Number of subjects: 18
Study 33620897 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-specific counseling
Number of subjects: 135
Study 33620897 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 135
Study 33327405 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertial flywheel (FW) resistance training
Number of subjects: 28
Study 33327405 — intervention group
Group type: COMPARATOR
Intervention: Free weight resistance training (TRA)
Number of subjects: 28
Study 33327405 — intervention group
Group type: EXPERIMENTAL
Intervention: FW-strong group
Number of subjects: 28
Study 35721646 — intervention group
Group type: EXPERIMENTAL
Intervention: ETB inflated with alkalinized lidocaine
Number of subjects: 60
Study 35721646 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (control group)
Number of subjects: 60
Study 32297784 — intervention group
Group type: COMPARATOR
Intervention: No-stress condition
Number of subjects: 39
Study 33529723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (OIT) with raw egg white powder, maintenance dose of 1 g of egg white protein for 8 months
Number of subjects: 50
Study 33529723 — intervention group
Group type: COMPARATOR
Intervention: Avoidance for 6 months followed by crossover to OIT
Number of subjects: 50
Study 34448547 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ascorbic acid (500 mg) administered 2 hours before colonoscopic resection and on days 2 and 3 post-polypectomy
Number of subjects: 153
Study 34448547 — intervention group
Group type: COMPARATOR
Intervention: Control group received normal saline
Number of subjects: 153
Study 34836304 — intervention group
Group type: EXPERIMENTAL
Intervention: High-amylose maize starch (HMS)
Number of subjects: 17
Study 34836304 — intervention group
Group type: EXPERIMENTAL
Intervention: Native banana starch (NBS)
Number of subjects: 17
Study 34836304 — intervention group
Group type: COMPARATOR
Intervention: Digestible maize starch (DMS)
Number of subjects: 17
Study 33362223 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular strength‐resistance training
Number of subjects: 30
Study 33362223 — intervention group
Group type: COMPARATOR
Intervention: Classic strength‐resistance training
Number of subjects: 30
Study 34275877 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard demand creation augmented by human‐centred design (HCD)‐informed approach
Number of subjects: 140
Study 34275877 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard demand creation plus offer of HIV self‐testing (HIVST)
Number of subjects: 140
Study 34275877 — intervention group
Group type: COMPARATOR
Intervention: IPC agents that reported reaching at least one man with demand creation
Number of subjects: 140
Study 32183859 — intervention group
Group type: EXPERIMENTAL
Intervention: Active training approach (model learning)
Number of subjects: 68
Study 32183859 — intervention group
Group type: COMPARATOR
Intervention: Passive training approach (reading manual-based instructions)
Number of subjects: 68
Study 32183859 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct supervision technique (supervision based on video analysis)
Number of subjects: 68
Study 32183859 — intervention group
Group type: COMPARATOR
Intervention: Indirect supervision technique (supervision based on verbal reporting)
Number of subjects: 68
Study 36435010 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive brivaracetam (BRV) treatment; median modal dose: 200 mg/day; median treatment duration: 2.67 years
Number of subjects: 740
Study 36435010 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive brivaracetam (BRV) treatment
Number of subjects: 740
Study 34013444 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term prophylactic intravenous antibiotics (7 days)
Number of subjects: 180
Study 34013444 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term prophylactic intravenous antibiotics (14 days)
Number of subjects: 180
Study 32400342 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel mass drug administration
Number of subjects: 0
Study 32400342 — intervention group
Group type: COMPARATOR
Intervention: Control strategies for schistosomiasis
Number of subjects: 0
Study 36078607 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental exposures (drinking water source, sanitation, exposure to animals, housing materials, season, residential area, food insecurity)
Number of subjects: 620
Study 33542479 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinatumomab (9 μg/day cycle 1 week 1, 28 μg/day thereafter for 4 weeks)
Number of subjects: 0
Study 33542479 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 33542479 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinatumomab or Chemotherapy (both groups)
Number of subjects: 0
Study 36469441 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral gavage (OG) administration of terbinafine (30 mg/kg)
Number of subjects: 7
Study 36469441 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioencapsulated (BEC) administration of terbinafine (30 mg/kg)
Number of subjects: 7
Study 34002564 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat grain moxibustion
Number of subjects: 200
Study 34002564 — intervention group
Group type: COMPARATOR
Intervention: Warming acupuncture
Number of subjects: 200
Study 32557180 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive framing with natural frequencies
Number of subjects: 1067
Study 32557180 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive framing with percentages
Number of subjects: 1067
Study 32557180 — intervention group
Group type: COMPARATOR
Intervention: Current practice PIL
Number of subjects: 1067
Study 36260424 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathlete (experimental group, 30 children)
Number of subjects: 40
Study 36260424 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching (control group, 10 children)
Number of subjects: 40
Study 33450081 — intervention group
Group type: EXPERIMENTAL
Intervention: omega-3 FAs
Number of subjects: 90
Study 33450081 — intervention group
Group type: COMPARATOR
Intervention: omega-6 FAs
Number of subjects: 90
Study 33450081 — intervention group
Group type: COMPARATOR
Intervention: no lipid emulsions
Number of subjects: 90
Study 35676697 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at acupoints with lower pain threshold (LPT group)
Number of subjects: 666
Study 35676697 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at acupoints with higher pain threshold (HPT group)
Number of subjects: 666
Study 35676697 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list group (no acupuncture)
Number of subjects: 666
Study 35676697 — intervention group
Group type: EXPERIMENTAL
Intervention: LPT group and HPT group
Number of subjects: 666
Study 34395335 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow mesenchymal stem cells (BM-MSC) - 5 infusions of 1×10^6 cells/kg for 3 weeks
Number of subjects: 9
Study 34395335 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT) plus placebo infusion of saline
Number of subjects: 9
Study 34395335 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow mesenchymal stem cells (BM-MSC)
Number of subjects: 9
Study 34269121 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 55447
Study 34269121 — intervention group
Group type: COMPARATOR
Intervention: tPA administration
Number of subjects: 55447
Study 34269121 — intervention group
Group type: COMPARATOR
Intervention: Decompressive hemicraniectomy (DHC)
Number of subjects: 55447
Study 34269121 — intervention group
Group type: COMPARATOR
Intervention: Total stroke admissions
Number of subjects: 55447
Study 33401473 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week resistance training + protein supplementation (RT + PRO)
Number of subjects: 39
Study 33401473 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 39
Study 36177452 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-s delay in cord clamping (60-s DCC)
Number of subjects: 123
Study 36177452 — intervention group
Group type: COMPARATOR
Intervention: PBCC, 30-s DCC, and I-UCM
Number of subjects: 123
Study 36177452 — intervention group
Group type: COMPARATOR
Intervention: I-UCM, 60-s DCC, and 30-s DCC
Number of subjects: 123
Study 32804268 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary recruitment maneuver (PRM)
Number of subjects: 84
Study 32804268 — intervention group
Group type: COMPARATOR
Intervention: Intraperitoneal anesthetic instillation (IAI)
Number of subjects: 84
Study 34773995 — intervention group
Group type: EXPERIMENTAL
Intervention: Low concentration popliteal-sciatic nerve block (SNB) with 0.125% bupivacaine [20 ml] and dexamethasone [5 mg]
Number of subjects: 50